Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.
Ann Oncol. 2002 Nov;13(11):1749-55. doi: 10.1093/annonc/mdf294.
Ann Oncol. 2002.
PMID: 12419747
Free article.
Clinical Trial.
A new therapeutical approach: topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum.
Sehouli J, Stengel D, Oskay G, Blohmer J, Kaubitzsch S, Lichtenegger W.
Sehouli J, et al. Among authors: oskay g.
J Obstet Gynaecol Res. 2003 Jun;29(3):123-31. doi: 10.1046/j.1341-8076.2003.00087.x.
J Obstet Gynaecol Res. 2003.
PMID: 12841693
Item in Clipboard
Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum.
Sehouli J, Stengel D, Oskay G, Blohmer J, Kaubitzsch S, Lichtenegger W; Ovarian Cancer Study Group of the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO).
Sehouli J, et al. Among authors: oskay g.
Onkologie. 2004 Feb;27(1):58-64. doi: 10.1159/000075607.
Onkologie. 2004.
PMID: 15007250
Clinical Trial.
Item in Clipboard
Detection of epithelial carcinoma cells in the blood of patients with gynaecological malignancies.
Sehouli J, Könsgen D, Nimpsch R, Oskay G, Stengel D, Oertel J, Lichtenegger W, Mustea A.
Sehouli J, et al. Among authors: oskay g.
Anticancer Res. 2003 Mar-Apr;23(2A):1093-7.
Anticancer Res. 2003.
PMID: 12820353
Item in Clipboard
Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies.
Sehouli J, Könsgen D, Nimpsch R, Stengel D, Oskay G, Mustea A, Oertel J, Lichtenegger W.
Sehouli J, et al. Among authors: oskay g.
Anticancer Res. 2003 Sep-Oct;23(5b):4133-40.
Anticancer Res. 2003.
PMID: 14666614
Item in Clipboard
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators.
Ray-Coquard I, et al.
N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361.
N Engl J Med. 2019.
PMID: 31851799
Clinical Trial.
Item in Clipboard
Cite
Cite